257 related articles for article (PubMed ID: 7567330)
1. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
Besunder JB; Anderson RL; Super DM
Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
[TBL] [Abstract][Full Text] [Related]
2. Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
Markowitz ME; Bijur PE; Ruff H; Rosen JF
Pediatrics; 1993 Aug; 92(2):265-71. PubMed ID: 8337028
[TBL] [Abstract][Full Text] [Related]
3. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
[TBL] [Abstract][Full Text] [Related]
4. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
5. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
6. Children with moderately elevated lead levels: is chelation with DMSA helpful?
O'Connor ME; Rich D
Clin Pediatr (Phila); 1999 Jun; 38(6):325-31. PubMed ID: 10378089
[TBL] [Abstract][Full Text] [Related]
7. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.
Besunder JB; Super DM; Anderson RL
J Pediatr; 1997 Jun; 130(6):966-71. PubMed ID: 9202621
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral meso-2,3-dimercaptosuccinic acid therapy for low-level childhood plumbism.
Liebelt EL; Shannon M; Graef JW
J Pediatr; 1994 Feb; 124(2):313-7. PubMed ID: 8301445
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
11. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
12. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
Gong Z; Evans HL
Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
[TBL] [Abstract][Full Text] [Related]
13. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.
Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI
PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378
[TBL] [Abstract][Full Text] [Related]
14. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
Cory-Slechta DA
J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
[TBL] [Abstract][Full Text] [Related]
15. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
[TBL] [Abstract][Full Text] [Related]
16. Oral treatment of avian lead intoxication with meso-2,3-dimercaptosuccinic acid.
Hoogesteijn AL; Raphael BL; Calle P; Cook R; Kollias G
J Zoo Wildl Med; 2003 Mar; 34(1):82-7. PubMed ID: 12723805
[TBL] [Abstract][Full Text] [Related]
17. Succimer and the reduction of tissue lead in juvenile monkeys.
Smith DR; Woolard D; Luck ML; Laughlin NK
Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
[TBL] [Abstract][Full Text] [Related]
18. [Lead intoxication in a group of workers in Germany].
Willi RF; Felgenhauer N; Eyer F; Buters JT; Zilker T
Dtsch Med Wochenschr; 2009 Dec; 134(50):2556-60. PubMed ID: 19998225
[TBL] [Abstract][Full Text] [Related]
19. Individual and combined effect of meso-2,3-dimercaptosuccinic acid and allicin on blood and tissue lead content in mice.
Aslani MR; Najarnezhad V; Mohri M
Planta Med; 2010 Feb; 76(3):241-4. PubMed ID: 19764011
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
